Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Clinical trial NCT06909253 · RECRUITING

Trial details

NCT number: NCT06909253
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Myasthenia Gravis, Generalized

Start date: 2025-05-15
Primary completion: 2029-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.